Cayman Islands, January 29, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours. Nasdaq Official Closing Price (NOCP)" is a process for ...
Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
Newsable Asianet News on MSN6d
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s WhyBiotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In ...
Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback